Introduction The increasing evidence of SARS‐CoV‐2 impact on the central nervous system
(CNS) raises key questions on its impact for risk of later life cognitive decline, Alzheimer's …

Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in
a substantial proportion of affected patients. While these symptoms arise acutely during the …

COVID‐19 causes lasting neurological symptoms in some survivors. Like other infections,
COVID‐19 may increase risk of cognitive impairment. This perspective highlights four …

Since patients with Alzheimer's disease are at higher risk for hospitalization and death in the
setting of COVID-19, additional precautions and protective measures should be put in place …

The COVID-19 pandemic has posed unique risks to people with Alzheimer disease and
dementia. Research from 2020 has shown that these people have a relatively high risk of …

Recovery from coronavirus disease 2019 (COVID-19) will be principally defined in terms of
remission from respiratory symptoms; however, both clinical and animal studies have shown …

Alzheimer's disease (AD) has emerged as a key comorbidity of coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide and has had …

The association between SARS‐CoV‐2 infection with increased risk for new‐onset
neurodegenerative diseases remains unclear. Therefore, this meta‐analysis aims to …